APA (7th ed.) Citation

CH, L., YP, C., JY, L., CY, C., WY, K., CL, L., . . . JH, K. (2024). Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antivirals. Journal of medical virology, 96(5), e29675. https://doi.org/10.1002/jmv.29675

Chicago Style (17th ed.) Citation

CH, Liu, et al. "Four Weeks of Off-treatment Follow-up Is Sufficient to Determine Virologic Responses at Off-treatment Week 12 in Patients with Hepatitis C Virus Infection Receiving Fixed-dose Pangenotypic Direct-acting Antivirals." Journal of Medical Virology 96, no. 5 (2024): e29675. https://doi.org/10.1002/jmv.29675.

MLA (9th ed.) Citation

CH, Liu, et al. "Four Weeks of Off-treatment Follow-up Is Sufficient to Determine Virologic Responses at Off-treatment Week 12 in Patients with Hepatitis C Virus Infection Receiving Fixed-dose Pangenotypic Direct-acting Antivirals." Journal of Medical Virology, vol. 96, no. 5, 2024, p. e29675, https://doi.org/10.1002/jmv.29675.